NDC 69605-002

Beleodaq

Belinostat

Beleodaq is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cenexi - Bla. The primary component is Belinostat.

• Product ID: 69605-002_d44fda43-af8e-4cd6-e053-2a95a90ace50
• NDC: 69605-002
• Product Type: Human Prescription Drug
• Proprietary Name: Beleodaq
• Generic Name: Belinostat
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2014-07-21
• Marketing Category: NDA /
• Application Number: NDA206256
• Labeler Name: CENEXI - BLA
• Substance Name: BELINOSTAT
• Active Ingredient Strength: 500 mg/10mL
• Pharm Classes: Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 69605-002-01

1 VIAL in 1 CARTON (69605-002-01) > 10 mL in 1 VIAL

• Marketing Start Date: 2014-07-21
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Beleodaq" or generic name "Belinostat"

NDC	Brand Name	Generic Name
68152-108	Beleodaq	Belinostat
69605-002	Beleodaq	Belinostat
72893-002	Beleodaq	Belinostat